1.
Laskin DM. Arthrocentesis for the treatment of internalderangements of the temporomandibular joint. Alpha Omegan.2009;102(2):46-50.
2.
Sato J, Segami N, Suzuki T, Kaneyama K, Yoshitake Y, NishikawaK. The expression of vascular endothelial growth factor insynovial tissues in patients with internal derangement of thetemporomandibular joint. Oral Surg Oral Med Oral Pathol OralRadiol Endod. 2002;93(3):251-256.
3.
Matsumoto K, Honda K, Ohshima M, et al. Cytokine profile insynovial fluid from patients with internal derangement of thetemporomandibular joint: a preliminary study. DentomaxillofacRadiol. 2006;35(6):432-441.
4.
Brennan PA, Ilankovan V. Arthrocentesis for temporomandibularjoint pain dysfunction syndrome. J Oral Maxillofac Surg.2006;64(6):949-951.
5.
Laskin DM. Arthroscopy versus arthrocentesis for treatinginternal derangements of the temporomandibular joint. OralMaxillofac Surg Clin North Am. 2018;30(3):325-328.
6.
Nitzan DW. Arthrocentesis--incentives for using this minimallyinvasive approach for temporomandibular disorders. OralMaxillofac Surg Clin North Am. 2006;18(3):311-328.
7.
Quinn JH, Bazan NG. Identification of prostaglandin E2 andleukotriene B4 in the synovial fluid of painful, dysfunctionaltemporomandibular joints. J Oral Maxillofac Surg.1990;48(9):968-971.
8.
Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J.Importance of proinflammatory cytokines in synovial fluidfrom 121 joints with temporomandibular disorders. Br J OralMaxillofac Surg. 2002;40(5):418-423.
9.
Fu K, Ma X, Zhang Z, Chen W. Tumor necrosis factor in synovialfluid of patients with temporomandibular disorders. J OralMaxillofac Surg. 1995;53(4):424-426.
10.
Fu K, Ma X, Zhang Z, Pang X, Chen W. Interleukin-6 in synovialfluid and HLA-DR expression in synovium from patients withtemporomandibular disorders. J Orofac Pain. 1995;9(2):131-137.
11.
Nitzan DW, Dolwick MF, Martinez GA. Temporomandibularjoint arthrocentesis: a simplified treatment for severe, limitedmouth opening. J Oral Maxillofac Surg. 1991;49(11):1163-1167.
12.
Shibata T, Murakami KI, Kubota E, Maeda H. Glycosaminoglycancomponents in temporomandibular joint synovial fluid as markersof joint pathology. J Oral Maxillofac Surg. 1998;56(2):209-213.
13.
de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, et al. Synovialinflammation, immune cells and their cytokines in osteoarthritis:a review. Osteoarthritis Cartilage. 2012;20(12):1484-1499.
14.
Ernberg M. The role of molecular pain biomarkers intemporomandibular joint internal derangement. J Oral Rehabil.2017;44(6):481-491.
15.
Luo P, Feng C, Jiang C et al. IL-37b alleviates inflammation inthe temporomandibular joint cartilage via IL-1R8 pathway. CellProlif. 2019;52(6):12692.
16.
Wake M, Hamada Y, Kumagai K, et al. Up-regulation ofinterleukin-6 and vascular endothelial growth factor-A in thesynovial fluid of temporomandibular joints affected by synovialchondromatosis. Br J Oral Maxillofac Surg. 2013;51(2):164-169.
17.
Hamada Y, Kondoh T, Holmlund AB, Sakota K, Nomura Y, SetoK. Cytokine and clinical predictors for treatment outcome ofvisually guided temporomandibular joint irrigation in patientswith chronic closed lock. J Oral Maxillofac Surg. 2008;66(1):29-34.
18.
Wang XD, Cui SJ, Liu Y, et al. Deterioration of mechanicalproperties of discs in chronically inflamed TMJ. J Dent Res.2014;93(11):1170-1176.
19.
Segami N, Miyamaru M, Nishimura M, Suzuki T, KaneyamaK, Murakami K. Does joint effusion on T2 magnetic resonanceimages reflect synovitis? Part 2. Comparison of concentrationlevels of proinflammatory cytokines and total protein in synovialfluid of the temporomandibular joint with internal derangementsand osteoarthrosis. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2002;94(4):515-521.
20.
Matsumoto K, Honda K, Ohshima M et al. Cytokine profile insynovial fluid from patients with internal derangement of thetemporomandibular joint: a preliminary study. DentomaxillofacRadiol. 2006;35(6):432-441.
21.
Nishimura M, Segami N, Kaneyama K, Suzuki T, MiyamaruM. Proinflammatory cytokines and arthroscopic findingsof patients with internal derangement and osteoarthritisof the temporomandibular joint. Br J Oral Maxillofac Surg.2002;40(1):68-71.
22.
Ulmner M, Sugars R, Naimi-Akbar A et al. Synovial tissuecytokine profile in disc displacement of the temporomandibularjoint. J Oral Rehabil. 2020;47(10):1202-1211.
23.
Gulen H, Ataoglu H, Haliloglu S, Isik K. Proinflammatorycytokines in temporomandibular joint synovial fluid before andafter arthrocentesis. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2009;107(5):1-4.
24.
Kellesarian SV, Al-Kheraif AA, Vohra F, et al. Cytokine profilein the synovial fluid of patients with temporomandibular jointdisorders: A systematic review. Cytokine. 2016;77:98-106.
25.
Kawashima M, Ogura N, Akutsu M, Ito K, Kondoh T. The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular jointresults from the suppression of PGE2 production. J Oral PatholMed. 2013;42(6):499-506